Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology crawled time : 15:01 save search
April 27-29, 2021: Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement - 04/27/2021 - 04/29/2021
Published: 2021-04-27 (Crawled : 15:01) - fda.gov
BMY | $48.99 -0.31% 0.41% 7.1M
|
Health Technology
|
| O: 0.17%
H: 0.42%
C: -0.06%
drug
Galectin Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference
Published: 2021-03-04 (Crawled : 15:01) - globenewswire.com
GALT | $3.38 10.46% 9.06% 240K
|
Health Technology
|
| O: -3.0%
H: 0.88%
C: -3.54%
life science galectin-3
PAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., Elected to AdvaMed Board of Directors
Published: 2021-03-01 (Crawled : 15:01) - globenewswire.com
PAVM | $1.87 -0.53% -1.62% 28K
|
Health Technology
|
| O: 3.81%
H: 1.9%
C: -5.5%
PAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM EST
Published: 2021-02-18 (Crawled : 15:01) - globenewswire.com
PAVM | $1.87 -0.53% -1.62% 28K
|
Health Technology
|
| O: -8.51%
H: 5.84%
C: 1.95%
Ocugen and Bharat Biotech Announce Execution of Definitive Agreement for the Commercialization of COVAXIN™ in the US Market
Published: 2021-02-02 (Crawled : 15:01) - globenewswire.com
OCGN | News A | $1.25 0.81% 3.88% 170K
|
Health Technology
|
| O: 14.92%
H: 79.33%
C: 56.73%
biotech commercialization
Interpace Biosciences Announces Contract for Thyroid Testing with Blue Cross Blue Shield of Florida
Published: 2021-01-28 (Crawled : 15:01) - globenewswire.com
IDXG | $1.4675 1.21% 16.27% 0
|
Health Technology
|
| O: 23.01%
H: 15.01%
C: -17.35%
test contract bioscience
Ayala Pharmaceuticals Announces First Patient Dosed in Phase 2 TENACITY Clinical Trial of AL101 for the Treatment of Patients with Notch-Activated Triple Negative Breast Cancer
Published: 2021-01-28 (Crawled : 15:01) - globenewswire.com
AYLA | $0.5036 5.84% -0.7% 0
|
Health Technology
|
| O: -9.93%
H: 10.29%
C: 5.55%
cancer treatment phase 2 breast cancer trial
Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
Published: 2021-01-12 (Crawled : 15:01) - globenewswire.com
CAPR | $4.82 -2.43% -2.7% 480K
|
Health Technology
|
| O: 17.31%
H: 15.73%
C: -4.66%
therapy treatment collaboration cap-1002 duchenne
GeoVax Awarded NIH Grant to Advance COVID-19 Vaccine Development
Published: 2021-01-11 (Crawled : 15:01) - globenewswire.com
GOVX | $1.54 -0.65% 1.27% 0
|
Health Technology
|
| O: 114.85%
H: 4.37%
C: -24.4%
covid vaccine granted covid-19 grant awards
PAVmed Announces Registered Direct Offering of its Common Stock Priced At-the-Market under Nasdaq Rules
Published: 2021-01-06 (Crawled : 15:01) - globenewswire.com
PAVM | $1.87 -0.53% -1.62% 28K
|
Health Technology
|
| O: -10.85%
H: 2.17%
C: -5.22%
offering nasdaq
CareDx Celebrates the Long-Awaited Passage of the Immuno Bill
Published: 2020-12-22 (Crawled : 15:01) - globenewswire.com
CDNA | $8.23 0.73% 0.49% 0
|
Health Technology
|
| O: 0.48%
H: 6.69%
C: 6.1%
Arcutis Biotherapeutics Added to Nasdaq Biotechnology Index
Published: 2020-12-21 (Crawled : 15:01) - globenewswire.com
ARQT | $8.74 -2.24% -2.35% 1.4M
|
Health Technology
|
| O: -0.07%
H: 1.35%
C: 0.24%
biotech nasdaq
PAVmed Announces Pricing of Additional $8.1 Million Common Stock Registered Direct Offering
Published: 2020-12-18 (Crawled : 15:01) - globenewswire.com
PAVM | $1.87 -0.53% -1.62% 28K
|
Health Technology
|
| O: -7.65%
H: 4.73%
C: 4.14%
offering
Blueprint Medicines Submits Supplemental New Drug Application to FDA for AYVAKIT™ (avapritinib) for the Treatment of Advanced Systemic Mastocytosis
Published: 2020-12-17 (Crawled : 15:01) - biospace.com/
BPMC | $92.29 1.85% 1.85% 790K
|
Health Technology
|
| O: 0.01%
H: 0.78%
C: 0.66%
drug fda treatment new drug application
Acer Therapeutics Announces Publication of Vascular Ehlers-Danlos Syndrome (vEDS) Patient Registry Data from SwedenAuthors report that celiprolol may have a protective effect in COL3A1-positive vEDS patients
Published: 2020-12-17 (Crawled : 15:01) - biospace.com/
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 0.0%
H: 8.61%
C: 0.41%
positive syndros celiprolol
EUROIMMUN Launches Novel ELISA for Detection of SARS-CoV-2 Antigen in Acutely Infected Patients
Published: 2020-12-16 (Crawled : 15:01) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: -0.14%
H: 0.23%
C: -2.9%
injection sars-cov-2 infections
PAVmed Announces Registered Direct Offering of its Common Stock
Published: 2020-12-11 (Crawled : 15:01) - globenewswire.com
PAVM | $1.87 -0.53% -1.62% 28K
|
Health Technology
|
| O: -10.16%
H: 10.12%
C: 5.95%
offering
Alpine Immune Sciences Appoints Natasha Hernday to Board of Directors
Published: 2020-12-11 (Crawled : 15:01) - biospace.com/
ALPN | $64.55 -0.05% -0.07% 2.9M
|
Health Technology
|
| O: -1.45%
H: 34.1%
C: 19.16%
Apellis Reports Pegcetacoplan Demonstrates Greater Treatment Responses and Quality-of-Life Improvements Compared to C5 Inhibitors for PNH
Published: 2020-12-07 (Crawled : 15:01) - globenewswire.com
APLS G | $48.72 2.27% 2.16% 110
|
Health Technology
|
| O: 0.32%
H: 3.29%
C: 2.33%
treatment response
Novo Nordisk A/S – Share repurchase programme
Published: 2020-12-07 (Crawled : 15:01) - globenewswire.com
NVO | News | $128.64 2.7% -1.37% 60K
|
Health Technology
|
| O: 1.3%
H: 0.2%
C: -0.7%
s
Gainers vs Losers
| 76% | 24% |
Top 10 Gainers
AGBA | $2.97 137.6% 54.87% 66M
|
Finance
HKIT | $1.33 30.39% 27.14% 39K
|
Technology Services
VRT 4 | $79.17 4.08% 19.36% 6.6M
|
Electronic Technology
PEGY | $0.0566 23.58% 15.65% 11M
|
Manufacturing
FOA 4 | $0.5144 -8.16% 15.43% 20
|
Finance and Insurance
BOF | $1.17 6.36% 14.73% 15K
|
LUCY | $0.2545 9.93% 13.94% 66K
|
n/a
PEB 4 | $15.45 2.45% 10.46% 130
|
Finance
MARA | $19.44 10.77% 10.28% 630K
|
Commercial Services
TSLA | News | $144.68 1.85% 9.01% 93M
|
Consumer Durables
Your saved searches
Save your searches and get alerts when important news are released.